GlassScriptPhysician profile
Milton Williams
NPI 1134680184
$7,339.84
in general payments reported to CMS, 2019-2025
27 companies · $1,588 in 2025
The $1,588 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,845 · 2024: $3,908 · 2025: $1,588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,774 · Travel and Lodging: $3,398 · Education: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,774.17 |
| Travel and Lodging | $3,397.68 |
| Education | $167.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $3,404.90 | 2024 | |
| Boston Scientific Corporation | $1,932.93 | 2023-2025 | Ams 700, Spaceoar Vue System - 10ml, Advance Xp |
| Axonics, INC. | $267.38 | 2023-2024 | Axonics, Bulkamid |
| Endo USA, INC. | $179.96 | 2024-2025 | Xiaflex, Aveed |
| Astellas Pharma US INC | $176.32 | 2025 | Xtandi |
| Ferring Pharmaceuticals INC. | $147.04 | 2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $120.97 | 2024-2025 | |
| Endo Pharmaceuticals INC. | $117.69 | 2023 | Xiaflex |
| Procept Biorobotics Corporation | $111.24 | 2025 | |
| Janssen Biotech, INC. | $108.59 | 2025 | Erleada |
| Seagen INC. | $99.99 | 2025 | |
| Telix Pharmaceuticals | $89.66 | 2025 | Illuccix |
| Karl Storz Endoscopy-America | $87.17 | 2023 | Flex-X / Image 1 S |
| Abbvie INC. | $64.67 | 2025 | |
| Merck Sharp & Dohme LLC | $59.43 | 2024-2025 | Keytruda, Keytruda Qlex |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $52.33 | 2025 | Gemtesa |
| Pfizer INC. | $50.83 | 2025 | |
| Calyxo, INC. | $49.56 | 2023-2025 | Cvac Aspiration System |
| Bioprotect Medical, INC. | $38.43 | 2025 | Bioprotect Balloon Implant System |
| Dendreon Pharmaceuticals LLC | $32.61 | 2025 | Provenge |
| Urogen Pharma, INC. | $29.27 | 2025 | |
| Verity Pharmaceuticals INC. | $27.55 | 2025 | Tlando |
| Alnylam Pharmaceuticals INC. | $22.78 | 2025 | Givlaari |
| Myriad Genetic Laboratories, INC. | $20.63 | 2025 | Prolaris |
| Teleflex LLC | $18.33 | 2024 | |
| Amgen INC. | $15.65 | 2025 | Krystexxa |
| Sagent Pharmaceuticals | $13.93 | 2025 | Glydo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Milton Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.